BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 20637775)

  • 1. An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies.
    Nielsen JS; Wick DA; Tran E; Nelson BH; Webb JR
    J Immunol Methods; 2010 Aug; 360(1-2):149-56. PubMed ID: 20637775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of T cell epitopes by the use of rapidly generated mRNA fragments.
    Britten CM; Meyer RG; Graf C; Huber C; Wölfel T
    J Immunol Methods; 2005 Apr; 299(1-2):165-75. PubMed ID: 15914199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of clonal mRNA as an antigenic format for the detection of antigen-specific T lymphocytes in IFN-gamma ELISPOT assays.
    Britten CM; Meyer RG; Frankenberg N; Huber C; Wölfel T
    J Immunol Methods; 2004 Apr; 287(1-2):125-36. PubMed ID: 15099761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient mRNA electroporation of peripheral blood mononuclear cells to detect memory T cell responses for immunomonitoring purposes.
    Van Camp K; Cools N; Stein B; Van de Velde A; Goossens H; Berneman ZN; Van Tendeloo V
    J Immunol Methods; 2010 Mar; 354(1-2):1-10. PubMed ID: 20138047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.
    Heine A; Grünebach F; Holderried T; Appel S; Weck MM; Dörfel D; Sinzger C; Brossart P
    Mol Ther; 2006 Feb; 13(2):280-8. PubMed ID: 16219490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
    J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of PSA-derived peptide antigens by T cells from prostate cancer patients without any prior stimulation.
    Chakraborty NG; Stevens RL; Mehrotra S; Laska E; Taxel P; Sporn JR; Schauer P; Albertsen PC
    Cancer Immunol Immunother; 2003 Aug; 52(8):497-505. PubMed ID: 12783216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo induction of viral antigen-specific CD8 T cell responses using mRNA-electroporated CD40-activated B cells.
    Van den Bosch GA; Ponsaerts P; Nijs G; Lenjou M; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    Clin Exp Immunol; 2005 Mar; 139(3):458-67. PubMed ID: 15730391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous ex vivo quantification of antigen-specific CD4+ and CD8+ T cell responses using in vitro transcribed RNA.
    Kreiter S; Konrad T; Sester M; Huber C; Türeci O; Sahin U
    Cancer Immunol Immunother; 2007 Oct; 56(10):1577-87. PubMed ID: 17361438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive ELISPOT assay for detection of CD8+ T lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients.
    Scheibenbogen C; Lee KH; Mayer S; Stevanovic S; Moebius U; Herr W; Rammensee HG; Keilholz U
    Clin Cancer Res; 1997 Feb; 3(2):221-6. PubMed ID: 9815676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
    Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
    Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patients.
    Knights AJ; Nuber N; Thomson CW; de la Rosa O; Jäger E; Tiercy JM; van den Broek M; Pascolo S; Knuth A; Zippelius A
    Cancer Immunol Immunother; 2009 Mar; 58(3):325-38. PubMed ID: 18663444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of CD8+ T-cell epitopes specific for immediate-early transactivator Rta of Epstein-Barr virus.
    Yu H; Srinivasan N; Ren E; Chan S
    Hum Immunol; 2005 May; 66(5):483-93. PubMed ID: 15935885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE.
    Berner BR; Tary-Lehmann M; Yonkers NL; Askari AD; Lehmann PV; Anthony DD
    Cell Immunol; 2005 May; 235(1):29-38. PubMed ID: 16181618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplexed combinatorial tetramer staining in a mouse model of virus infection.
    Cukalac T; Valkenburg SA; La Gruta NL; Turner SJ; Doherty PC; Kedzierska K
    J Immunol Methods; 2010 Aug; 360(1-2):157-61. PubMed ID: 20558170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
    Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
    Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
    Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priming and activation of human ovarian and breast cancer-specific CD8+ T cells by polyvalent Listeria monocytogenes-based vaccines.
    Sinnathamby G; Lauer P; Zerfass J; Hanson B; Karabudak A; Krakover J; Secord AA; Clay TM; Morse MA; Dubensky TW; Brockstedt DG; Philip R; Giedlin M
    J Immunother; 2009 Oct; 32(8):856-69. PubMed ID: 19752748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.